Adalimumab and Certolizumab Pegol for the Treatment of Crohn's Disease: Does BMI Make a Difference?

Authors

Keywords

Journal

Volume 140, Issue 5, Pages S-588

Publisher

Elsevier BV

Online

2018-05-10

DOI

10.1016/s0016-5085(11)62434-7

Explore over 38,000 international journals covering a vast array of academic fields.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started